recombinant human tissue plasminogen kinase derivative
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human tissue plasminogen kinase derivative, covering 2019-07-22 to 2019-07-22. Get the full timeline:
Most recent: Clinical Trial Update: A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke. [Phase 2]